1. Home
  2. CYCC vs UFG Comparison

CYCC vs UFG Comparison

Compare CYCC & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • UFG
  • Stock Information
  • Founded
  • CYCC 1992
  • UFG 2021
  • Country
  • CYCC Malaysia
  • UFG Singapore
  • Employees
  • CYCC N/A
  • UFG N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • UFG Oil Refining/Marketing
  • Sector
  • CYCC Health Care
  • UFG Energy
  • Exchange
  • CYCC Nasdaq
  • UFG Nasdaq
  • Market Cap
  • CYCC 61.2M
  • UFG 64.8M
  • IPO Year
  • CYCC N/A
  • UFG 2025
  • Fundamental
  • Price
  • CYCC $0.35
  • UFG $2.44
  • Analyst Decision
  • CYCC
  • UFG
  • Analyst Count
  • CYCC 0
  • UFG 0
  • Target Price
  • CYCC N/A
  • UFG N/A
  • AVG Volume (30 Days)
  • CYCC 3.6M
  • UFG 256.9K
  • Earning Date
  • CYCC 08-13-2025
  • UFG 01-01-0001
  • Dividend Yield
  • CYCC 41.68%
  • UFG N/A
  • EPS Growth
  • CYCC N/A
  • UFG N/A
  • EPS
  • CYCC N/A
  • UFG 0.01
  • Revenue
  • CYCC $14,000.00
  • UFG $155,193,013.00
  • Revenue This Year
  • CYCC $137.21
  • UFG N/A
  • Revenue Next Year
  • CYCC N/A
  • UFG N/A
  • P/E Ratio
  • CYCC N/A
  • UFG $416.16
  • Revenue Growth
  • CYCC N/A
  • UFG 119.24
  • 52 Week Low
  • CYCC $0.25
  • UFG $1.15
  • 52 Week High
  • CYCC $39.84
  • UFG $6.13
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 25.10
  • UFG N/A
  • Support Level
  • CYCC $0.29
  • UFG N/A
  • Resistance Level
  • CYCC $0.46
  • UFG N/A
  • Average True Range (ATR)
  • CYCC 0.19
  • UFG 0.00
  • MACD
  • CYCC 0.05
  • UFG 0.00
  • Stochastic Oscillator
  • CYCC 6.33
  • UFG 0.00

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About UFG Uni-Fuels Holdings Limited Class A Ordinary Shares

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

Share on Social Networks: